Sub-Saharan Africa Pharmaceuticals & Healthcare Q3 2018
: Sub-Saharan Africa will remain a challenging environment for multinational pharmaceutical companies. Besides the lessattractive commercial profile, the region suffers from wide disparities in regulatory procedures, a lack of enforced patent laws, and ageneral lack of transparency that ensures the region lags behind others globally for revenue-earning opportunities. Despite this, theregion's pharmaceutical markets will continue to provide long-term opportunities for drugmakers on the back of expandinghealthcare access and an evolving epidemiological-and-demographic profile. It is vital that drugmakers identify those markets withhigh growth potential as well as the levels of risk involved.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook